| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $124.02M | $73.38M | $67.77M | $71.45M | $72.77M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$124.02M | -$73.38M | -$67.77M | -$71.45M | -$72.77M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $24.26B | $6.55B | $3.25B | -$538.96M | -$1.40B |
| EPS (basic) | 31.9600 | 10.0600 | 4.4200 | -0.6500 | -1.6500 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |